Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., filed a Form 4 on November 18, 2026, disclosing the sale of 22,390 ordinary shares across two transactions on November 16 and November 17, 2026, pursuant to a Rule 10b5-1 trading plan.
Key Highlights
- First sale: 12,462 ordinary shares disposed of on November 16, 2026, at a weighted average price of $11.5522, with individual transaction prices ranging from $11.41 to $11.65.
- Second sale: 9,928 ordinary shares disposed of on November 17, 2026, at a weighted average price of $10.6608, with individual transaction prices ranging from $10.45 to $11.04.
- Remaining holdings: Following both transactions, Jewell directly held 404,345 ordinary shares of Cellebrite DI Ltd.
- Source of shares: The filing states the disposed shares were originally granted on November 15, 2023 as restricted stock units (RSUs), and the dispositions are associated with the reporting person's tax obligations connected to RSU vesting.
- Trading plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2026.
- Exchange and ticker: Cellebrite DI Ltd. trades as NASDAQ:CLBT.
Jewell Marcus RSU-Related Share Sales: Transaction Details
According to the filing, Marcus Jewell, identified as Global Chief Revenue Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), reported two disposals of ordinary shares with par value NIS 0.00001 in a Form 4 filed November 18, 2026. The first transaction, dated November 16, 2026, involved the sale of 12,462 shares at a weighted average price of $11.5522. The filing notes these shares were sold in multiple transactions at prices ranging from $11.41 to $11.65, inclusive.
The second transaction, dated November 17, 2026, covered the sale of 9,928 shares at a weighted average price of $10.6608. Per the filing, those sales occurred at prices ranging from $10.45 to $11.04, inclusive. After both transactions, the reporting person's direct beneficial ownership stood at 404,345 ordinary shares, down from an implied pre-transaction figure of 426,735 shares.
The filing states that the shares sold on November 16, 2026, were originally granted as RSUs on November 15, 2023, and that the dispositions are "associated with tax obligations of the reporting person associated with the vesting of the RSUs." The filing further states that both sales were "effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2026." The filing also notes that the box indicating a transaction made pursuant to Rule 10b5-1(c) was checked. Jewell undertakes, per the filing, to provide full details of shares sold at each separate price upon request by the issuer, any security holder, or SEC staff.
What Was Disclosed
Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., disclosed the disposal of 22,390 ordinary shares over two days in November 2026 under a pre-established Rule 10b5-1 plan, with the sales linked to tax obligations from RSU vesting. Post-transaction beneficial ownership was reported as 404,345 shares held directly.



Please wait processing your request...